ReviewFrontiers in immunology2023

The good and the bad of T cell cross-reactivity: challenges and opportunities for novel therapeutics in autoimmunity and cancer.

Cécile Gouttefangeas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.